BIONET Corp. (1784.TWO)
- Previous Close
72.40 - Open
72.40 - Bid 72.40 x --
- Ask 72.60 x --
- Day's Range
71.80 - 73.50 - 52 Week Range
57.51 - 162.01 - Volume
89,812 - Avg. Volume
254,110 - Market Cap (intraday)
3.664B - Beta (5Y Monthly) 0.50
- PE Ratio (TTM)
43.88 - EPS (TTM)
1.65 - Earnings Date --
- Forward Dividend & Yield 0.71 (0.98%)
- Ex-Dividend Date Sep 19, 2024
- 1y Target Est
--
BIONET Corp. provides cell therapy services in Taiwan and internationally. The company offers stem cell banking services, including stem cell storage, mesenchymal stem cell storage, dental stem cell storage, adipose stem cell, and peripheral blood stem cells and immune cells; and genetic testing services. It also provides stem anti-aging and ANIKINE series products; and Exosome, a novel cell-free therapy. In addition, the company offers regenerative medicine, analytical testing, clinical and preclinical research, and commercialized cell-derived products. BIONET Corp. was founded in 1989 and is based in Taipei City, Taiwan.
www.bionetcorp.com--
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: 1784.TWO
View MorePerformance Overview: 1784.TWO
Trailing total returns as of 5/6/2025, which may include dividends or other distributions. Benchmark is TSEC CAPITALIZATION WEIGHTED ST (^TWII) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 1784.TWO
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 1784.TWO
View MoreValuation Measures
Market Cap
3.66B
Enterprise Value
2.18B
Trailing P/E
43.88
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
3.01
Price/Book (mrq)
2.75
Enterprise Value/Revenue
1.79
Enterprise Value/EBITDA
14.65
Financial Highlights
Profitability and Income Statement
Profit Margin
6.85%
Return on Assets (ttm)
1.42%
Return on Equity (ttm)
3.39%
Revenue (ttm)
1.22B
Net Income Avi to Common (ttm)
83.7M
Diluted EPS (ttm)
1.65
Balance Sheet and Cash Flow
Total Cash (mrq)
1.57B
Total Debt/Equity (mrq)
3.93%
Levered Free Cash Flow (ttm)
-23.02M